Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 17,699 shares at $51.28 ($895K) on 2021-03-08, disclosed to the SEC on 2021-03-08.
Open-market sale of $895k KYMR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.46 | 7,699 | $388K | 43.4% |
| 2 | $50.46 | 7,699 | $388K | 43.4% |
| 3 | $51.28 | 2,300 | $118K | 13.2% |
| 4 | $52.15 | 1 | $52 | 0.0% |
| Total | $50.57 avg | 17,699 | $895K | 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |